Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

R

RARE

Ultragenyx Pharmaceutical Inc

26.69

Jul 28 • 4:35 AM ET -0.20 (-0.74%)

Healthcare Biotechnology USA Mid NASD

Peers: BMRN RYTM KRYS MIRM PTCT IONS ALNY INCY VRTX KOD

| Held by: VTI XBI VB IWM VBK VXF VTWO IBB IWN SCHA

Scroll to Statements

Index	RUT
Market Cap	2.63B
Enterprise Value	3.41B
Income	-609.36M
Sales	669.43M
Book/sh	-2.41
Cash/sh	4.27
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	1371
IPO	Jan 31, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	3.93
P/B	-
P/C	6.24
P/FCF	-
EV/EBITDA	-
EV/Sales	5.10
Quick Ratio	1.85
Current Ratio	2.02
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-6.11
EPS next Y	-0.64
EPS next Q	-1.21
EPS this Y	26.03%
EPS next Y	85.10%
EPS next 5Y	-
EPS past 3/5Y	16.78% -13.72%
Sales past 3/5Y	22.81% 19.95%
EPS Y/Y TTM	-3.82%
Sales Y/Y TTM	13.33%
EPS Q/Q	-17.21%
Sales Q/Q	-2.36%
Earnings	May 05 AMC
EPS/Sales Surpr.	-23.67% -14.03%

Insider Own	8.95%
Insider Trans	-1.60%
Inst Own	95.78%
Inst Trans	-0.94%
ROA	-46.73%
ROE	-656.54%
ROIC	-68.31%
Gross Margin	78.49%
Oper. Margin	-83.92%
Profit Margin	-91.03%
SMA20	-14.00%
SMA50	-2.35%
SMA200	-1.56%
Trades

Shs Outstand	98.00M
Shs Float	89.67M
Short Float	14.98%
Short Ratio	6.18
Short Interest	13.44M
52W High	39.89 -33.09%
52W Low	18.29 45.93%
Volatility	4.11% 5.20%
ATR (14)	1.39
RSI (14)	36.77
Beta	0.35
Rel Volume	0.00
Avg Volume	2.17M
Volume	10

Perf Week	-6.74%
Perf Month	-13.26%
Perf Quarter	11.25%
Perf Half Y	9.79%
Perf YTD	16.04%
Perf Year	-3.33%
Perf 3Y	-38.09%
Perf 5Y	-67.17%
Perf 10Y	-56.25%
Recom	1.40
Target Price	53.26
Prev Close	26.89
Price	26.69
Change	-0.74%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)